Metabolic syndrome biomarkers and prostate cancer risk in the UK Biobank
We investigated the association between metabolic syndrome (MetS) and its components and risk of prostate cancer (PCa) in a cohort of men enrolled in the UK Biobank. <br><br> Our study cohort included 220 622 PCa‐free men with baseline measurements of triglycerides (TG), HDL‐cholesterol...
Main Authors: | Monroy-Iglesias, MJ, Russell, B, Crawley, D, Allen, NE, Travis, R, Perez-Cornago, A, Van Hemelrijck, M, Beckmann, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2020
|
Similar Items
-
Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank
by: Perez-Cornago, A, et al.
Published: (2020) -
Haematological markers and prostate cancer risk: a prospective analysis in UK Biobank
by: Watts, EJ, et al.
Published: (2020) -
The prospective association between meat intake and prostate cancer risk in UK Biobank
by: Perez-Cornago, A, et al.
Published: (2018) -
Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study
by: Perez-Cornago, A, et al.
Published: (2017) -
Association between metabolic syndrome and risk of incident dementia in UK Biobank
by: Qureshi, D, et al.
Published: (2023)